MarketWatch

Boehringer Ingelheim launches VETMEDIN(R) Solution (pimobendan oral solution), first oral solution approved by the FDA for congestive heart failure in dogs

-- Heart disease in dogs is almost as common as it is in humans, affecting approximately 10 percent of dogs in their lifetime1 -- Previous studies have shown that VETMEDIN(R) could help improve the ...
Longview News-Journal

Boehringer Ingelheim launches VETMEDIN® Solution (pimobendan oral solution), first oral solution approved by the FDA for congestive heart failure in dogs

Since VETMEDIN ® was first introduced 25 years ago, dogs and their owners around the world have enjoyed more than 1 million years of additional life to love. 4 VETMEDIN ® Chewable Tablets are approved ...